GITNUX MARKETDATA REPORT 2024
Losartan Efficacy Timelinestatistics
Losartan efficacy is expected to peak within 3-6 weeks of initiation and is maintained over the long term in patients with hypertension.
Statistic 1
"Around 20% of patients may experience dizziness from losartan."
Statistic 2
"Losartan reduces the risk of stroke in patients with hypertension by about 25%."
Statistic 3
"Losartan is effective in controlling blood pressure in approximately 60-70% of patients."
Statistic 4
"Losartan can significantly reduce left ventricular hypertrophy in patients with hypertension."
Statistic 5
"The maximum blood pressure-lowering effect of losartan is typically observed 3-6 hours after dosing."
Statistic 6
"Significant blood pressure reductions with losartan are typically seen within 1-2 weeks of starting therapy."
Statistic 7
"Losartan increases plasma renin activity, reducing the levels of angiotensin II."
Statistic 8
"Losartan decreases the risk of hospitalization for heart failure by 25%."
Statistic 9
"Losartan is often used in a once-daily dosing regimen for hypertension."
Statistic 10
"A 100 mg dose of losartan has a more sustained blood pressure-lowering effect than a 50 mg dose."
Statistic 11
"Losartan begins to lower blood pressure within 1 hour of administration."
Statistic 12
"In patients with diabetic nephropathy, losartan slows the progression of kidney disease."
Statistic 13
"Losartan is more effective in lowering blood pressure in patients under 65 compared to those above 65."
Statistic 14
"Long-term studies have shown that losartan maintains its blood pressure-lowering effect for up to 2 years."
Statistic 15
"Losartan's antihypertensive effect lasts for about 24 hours."
Statistic 16
"Losartan is associated with a lower incidence of adverse effects compared to other ARBs."
Statistic 17
"Losartan's effects on blood pressure are partly mediated through its active metabolite, EXP3174."
Statistic 18
"Losartan has been found effective in 80% of patients with isolated systolic hypertension."
Statistic 19
"Losartan has been shown to reduce proteinuria by about 35% in patients with type 2 diabetes."
Statistic 20
"Losartan has a bioavailability of about 33%."
Jannik Lindner
Can You Trust Our Report?
The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.
